Renal failure and rhabdomyolysis associated with sitagliptin and simvastatin use. But what about the amiodarone?
Boucher
B J
BJ
D000638:Amiodarone / Q000008:administration & dosage; D000075202:Contraindications; D054873:Dipeptidyl-Peptidase IV Inhibitors; D004359:Drug Therapy, Combination; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000008:administration & dosage; D000960:Hypolipidemic Agents; D027381:Liver-Specific Organic Anion Transporter 1; D008297:Male; D027361:Organic Anion Transporters; D011719:Pyrazines; D051437:Renal Insufficiency / Q000150:complications / Q000188:drug therapy; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000235:genetics; D019821:Simvastatin / Q000008:administration & dosage; D000068900:Sitagliptin Phosphate; D014230:Triazoles; D006113:United Kingdom; D014481:United States
D054873:Dipeptidyl-Peptidase IV Inhibitors; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D027381:Liver-Specific Organic Anion Transporter 1; D027361:Organic Anion Transporters; D011719:Pyrazines; C503999:SLCO1B1 protein, human; D014230:Triazoles; D019821:Simvastatin; D000638:Amiodarone; D000068900:Sitagliptin Phosphate